ATE273302T1 - Diazocinderivate und deren verwendung als tryptase inhibitoren - Google Patents
Diazocinderivate und deren verwendung als tryptase inhibitorenInfo
- Publication number
- ATE273302T1 ATE273302T1 AT02704674T AT02704674T ATE273302T1 AT E273302 T1 ATE273302 T1 AT E273302T1 AT 02704674 T AT02704674 T AT 02704674T AT 02704674 T AT02704674 T AT 02704674T AT E273302 T1 ATE273302 T1 AT E273302T1
- Authority
- AT
- Austria
- Prior art keywords
- tryptase inhibitors
- diazocine
- derivatives
- diazocine derivatives
- inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Urology & Nephrology (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Transplantation (AREA)
- Otolaryngology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Ophthalmology & Optometry (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
- Plural Heterocyclic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP01102098 | 2001-01-31 | ||
PCT/EP2002/000831 WO2002060895A1 (en) | 2001-01-31 | 2002-01-26 | Diazocine derivatives and their use as tryptase inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE273302T1 true ATE273302T1 (de) | 2004-08-15 |
Family
ID=8176347
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT02704674T ATE273302T1 (de) | 2001-01-31 | 2002-01-26 | Diazocinderivate und deren verwendung als tryptase inhibitoren |
Country Status (12)
Country | Link |
---|---|
US (1) | US6924305B2 (de) |
EP (1) | EP1358182B1 (de) |
JP (1) | JP2004517943A (de) |
AT (1) | ATE273302T1 (de) |
AU (1) | AU2002238522B8 (de) |
CA (1) | CA2438594A1 (de) |
DE (1) | DE60200935T2 (de) |
DK (1) | DK1358182T3 (de) |
ES (1) | ES2225758T3 (de) |
PT (1) | PT1358182E (de) |
SI (1) | SI1358182T1 (de) |
WO (1) | WO2002060895A1 (de) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2278928T3 (es) | 2001-06-19 | 2007-08-16 | Altana Pharma Ag | Inhibidores de triptasa. |
WO2006044133A1 (en) * | 2004-09-24 | 2006-04-27 | Axys Pharmaceuticals, Inc. | Active ketone inhibitors of tryptase |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH10501238A (ja) | 1994-06-01 | 1998-02-03 | アリス ファーマシューティカル コーポレイション | 肥満細胞媒介症状を治療するための組成物及び方法 |
SI9520101A (en) * | 1994-09-23 | 1997-12-31 | Arris Pharm Corp | Compositions and methods for treating mast-cell inflammatory condition |
CZ29799A3 (cs) | 1996-07-30 | 1999-06-16 | Arris Pharmaceutical Corporation | Disubstituovaná cyklická sloučenina, způsob její výroby, farmaceutický přípravek a způsob léčení onemocnění živočicha |
WO1999012918A1 (fr) | 1997-09-05 | 1999-03-18 | Yoshitomi Pharmaceutical Industries, Ltd. | Inhibiteur de la tryptase |
EP1030844A1 (de) | 1997-11-10 | 2000-08-30 | Array Biopharma Inc. | Verbindungen, die die aktivität von tryptase hemmen |
US6221914B1 (en) | 1997-11-10 | 2001-04-24 | Array Biopharma Inc. | Sulfonamide bridging compounds that inhibit tryptase activity |
ES2233025T3 (es) | 1998-02-06 | 2005-06-01 | Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. | Agente inhibidores de la triptasa. |
EP1060171A2 (de) | 1998-02-06 | 2000-12-20 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Tryptase-inhibitoren |
AU5625499A (en) | 1998-09-04 | 2000-03-27 | Altana Pharma Ag | Novel pyranoses |
DE19937721A1 (de) | 1999-08-10 | 2001-02-15 | Max Planck Gesellschaft | Neue Diketopiperazine |
DE60014932T2 (de) | 1999-08-10 | 2005-10-13 | Altana Pharma Ag | Diazocindionderivate und ihre verwendung als tryptase inhibitoren |
AU778965B2 (en) | 1999-09-14 | 2004-12-23 | Altana Pharma Ag | Tryptase inhibitors |
CA2392127A1 (en) | 1999-12-20 | 2001-06-28 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Tryptase inhibitors |
TR200402322T4 (tr) | 1999-12-20 | 2004-12-21 | Altana Pharma Ag | Triptaz inhibitörler |
-
2002
- 2002-01-26 DK DK02704674T patent/DK1358182T3/da active
- 2002-01-26 SI SI200230037T patent/SI1358182T1/xx unknown
- 2002-01-26 AU AU2002238522A patent/AU2002238522B8/en not_active Ceased
- 2002-01-26 JP JP2002561044A patent/JP2004517943A/ja not_active Withdrawn
- 2002-01-26 DE DE60200935T patent/DE60200935T2/de not_active Expired - Fee Related
- 2002-01-26 CA CA002438594A patent/CA2438594A1/en not_active Abandoned
- 2002-01-26 ES ES02704674T patent/ES2225758T3/es not_active Expired - Lifetime
- 2002-01-26 EP EP02704674A patent/EP1358182B1/de not_active Expired - Lifetime
- 2002-01-26 PT PT02704674T patent/PT1358182E/pt unknown
- 2002-01-26 WO PCT/EP2002/000831 patent/WO2002060895A1/en active IP Right Grant
- 2002-01-26 AT AT02704674T patent/ATE273302T1/de not_active IP Right Cessation
- 2002-01-26 US US10/466,906 patent/US6924305B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CA2438594A1 (en) | 2002-08-08 |
US6924305B2 (en) | 2005-08-02 |
DE60200935T2 (de) | 2005-09-01 |
SI1358182T1 (en) | 2005-02-28 |
AU2002238522B8 (en) | 2007-01-18 |
ES2225758T3 (es) | 2005-03-16 |
DE60200935D1 (de) | 2004-09-16 |
AU2002238522A1 (en) | 2002-08-12 |
EP1358182B1 (de) | 2004-08-11 |
WO2002060895A1 (en) | 2002-08-08 |
JP2004517943A (ja) | 2004-06-17 |
US20040072762A1 (en) | 2004-04-15 |
EP1358182A1 (de) | 2003-11-05 |
PT1358182E (pt) | 2004-12-31 |
AU2002238522B2 (en) | 2006-12-21 |
DK1358182T3 (da) | 2004-12-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60310576D1 (en) | 2-hydroxy-6-phenylphenanthridine als pde-4-hemmer | |
ATE353217T1 (de) | 3-hydroxy-6-phenylphenanthridine als pde-4 inhibitoren | |
BRPI0608886B8 (pt) | derivados de n-sulfonilpirróis e seus usos | |
DE69910831D1 (de) | Epothilonderivate und ihre verwendung als antitumormittel | |
HRP20050228A2 (en) | Novel phenanthridines | |
ES2186874T3 (es) | Analogos de m-amidinofenilo como inhibidores del factor xa. | |
DE60105418D1 (de) | Serinprotease-inhibitoren | |
PT1086096E (pt) | Benzamidas com substituintes etra-hidrofuraniloxi como inibidores da fosfodiesterase 4 | |
ATE391715T1 (de) | Heterozyklische mutilinester und deren verwendung als bakterizide | |
TR200201128T2 (tr) | PDE4 inhibitörleri olarak tetrahidrotiyopiranfitalazinon türevleri. | |
NO20064417L (no) | Nye isoamidosubstituertehydroksy-6-fenylfenantridiner | |
ATE343582T1 (de) | Derivate von (6, 7-dihydro -5h-imidazo(1,2 - a)imidazol -3 -sulfonylamino)-propionamid und deren verwendung als inhibitoren der interaktion von cams und leukointreginen | |
DE60202669D1 (de) | 6-phenylbenzonaphthyidine | |
EA200301101A1 (ru) | Производные пиперазина и их применение в качестве ингибиторов pde4 | |
ATE371662T1 (de) | Siliziumverbindungen und deren verwendung | |
DE69810629D1 (de) | Beta-alkoxyacrylate gegen malaria | |
DK1244643T3 (da) | Tryptaseinhibitorer | |
ATE508130T1 (de) | 3-oxa-10-aza-phenanthrene als pde4- oder pde3/4- inhibitoren | |
DE60200935D1 (de) | Diazocinderivate und deren verwendung als tryptase inhibitoren | |
DK1244614T3 (da) | Tryptase-inhibitorer | |
ATE348803T1 (de) | Tryptase-inhibitoren | |
ATE279398T1 (de) | Diazocindionderivate und ihre verwendung als tryptase inhibitoren | |
DE602004009313D1 (de) | Organosiliziumverbindungen und deren verwendung | |
ATE321760T1 (de) | N-aryl-2-oxazolidinone und deren derivate | |
DE60311000D1 (de) | Indolderivate und deren verwendung als 5-ht liganden |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1358182 Country of ref document: EP |
|
REN | Ceased due to non-payment of the annual fee |